iDose TR marks a breakthrough in glaucoma care, offering a small implant that delivers continuous medication to lower eye pressure. This innovative solution is designed for those managing open-angle glaucoma or ocular hypertension, making treatment easier and more effective.
iDose TR is an FDA-approved surgical treatment for glaucoma. It delivers medication continuously to lower eye pressure over time. The implant is small and designed for comfort. It helps people with open-angle glaucoma or ocular hypertension manage their condition more easily.
Glaucoma is a common eye disease, especially in people over 65. It slowly damages the optic nerve and can lead to vision loss. Because it often starts without symptoms, many people don’t know they have it until serious damage has happened. That’s why early diagnosis and treatment matter.
To protect vision, it’s important to keep eye pressure under control. Most treatments use eye drops, but those can be hard to use every day. People forget, or they stop because of side effects. iDose TR offers another option—it helps manage eye pressure long-term without the daily routine of drops.
iDose TR is a tiny implant—about 200 times smaller than a single eye drop. It’s placed inside the front part of the eye through a small incision, even smaller than the one used in cataract surgery. Once in place, it stays put. There’s no need to worry about it moving or causing discomfort.
The implant slowly releases travoprost, a medication that lowers eye pressure. This steady release keeps the pressure down all day and night. For many people, that means they can stop using daily eye drops—or at least use them less often.
iDose TR sits inside the eye, held securely in the tissue. It delivers a steady dose of medication right where it’s needed. The drug helps the eye drain fluid better, which lowers pressure. Because the medication is always working, it avoids the highs and lows that happen with eye drops. This helps keep eye pressure stable and supports long-term vision health.
One of the most challenging aspects of managing glaucoma with prescription eye drops is adherence. Many patients struggle with the daily regimen required to keep their eye pressure under control, which can lead to inconsistent treatment and, ultimately, diminished visual outcomes. iDose TR offers several key benefits that address these challenges:
The implant continuously releases medication over an extended period, ensuring a steady therapeutic effect without the need for daily administration.
With iDose TR in place, many patients can reduce or eliminate the need for additional topical medications, easing the burden of complex treatment schedules.
Clinical studies have shown that the most common side effects are mild, and the implant has a proven record of safety and tolerability.
The surgical implantation of iDose TR is performed with a small incision, much smaller than those used in standard cataract procedures, resulting in a quick recovery and minimal discomfort.
iDose TR offers a safe, low-maintenance option for managing glaucoma. Backed by strong clinical data and a minimally invasive implantation process, it’s designed to ease the treatment burden while keeping risks low and comfort high.
Clinical trials show that most side effects—like eye redness or mild inflammation—are temporary and occurred in only a small percentage of patients (2% to 6%).
Unlike some traditional treatments, iDose TR hasn’t been linked to serious issues like corneal damage or tissue loss, making it a reassuring choice for many patients.
The implant is placed through a tiny incision—smaller than those used in cataract surgery—helping to preserve the eye’s structure and support faster healing.
Performed under local anesthesia, the outpatient procedure is quick and painless. Most patients return home the same day and resume normal activities within 24 to 48 hours.
If you're looking for a convenient and effective solution for glaucoma management, reach out to a qualified optometrist or ophthalmologist listed with Specialty Vision. They can provide personalized care and help determine if iDose TR is the right choice for you.
Sticking to a daily eye drop routine can be tough. People often forget doses or have trouble using the drops correctly. That can make treatment less effective.
iDose TR removes that problem. It delivers medication continuously inside the eye, so there’s no need to remember daily drops. This steady release helps keep eye pressure stable and reduces the stress of managing a strict routine.
The implant can work for up to four years without needing to be replaced. That means fewer doctor visits and more freedom in daily life. It’s a simpler way to manage glaucoma—and a reliable option for people who want less hassle.
Many patients and caregivers wonder about the fundamental differences between iDose TR and traditional glaucoma eye drops. Traditional eye drops, while effective when used correctly, face several hurdles:
iDose TR addresses these challenges head on. Its continuous-release mechanism means that therapeutic levels of travoprost are maintained steadily, resulting in consistent eye pressure control. With the implant securely anchored, there’s no need to worry about missing a dose or misapplying drops. Ultimately, iDose TR simplifies treatment and helps ensure that the patient’s eye receives the consistent care it needs, all while reducing the overall treatment load.
The implantation procedure is designed to be minimally invasive, and most patients report little to no discomfort during the surgery. The device is so small that once it is implanted, you typically won’t feel it.
Yes, iDose TR is anchored in the scleral tissue of the eye, ensuring that it stays in place reliably over the treatment period.
The implant is designed to release medication consistently over an extended period—up to four years. When the drug is depleted, the implant can be safely removed and replaced if necessary.
With iDose TR, you are relieved from the daily chore of eye drop application. This means fewer interruptions and a simpler, more convenient treatment routine.
If you're looking for a convenient and effective solution for glaucoma management, reach out to a qualified optometrist or ophthalmologist listed with Specialty Vision. They can provide personalized care and help determine if iDose TR is the right choice for you.
iDose TR is an advanced glaucoma treatment option that provides consistent eye pressure management with a small, FDA-approved implant.
